New cancer risk gene found
Carrying a mutated BRIP1 gene doubles the risk of breast cancer — by aged 70 these women's risk rises from 1-in-12 to 1-in-6.
Breast cancer
New Cancer Drug Hope
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
EU challenge to worldwide BRCA2 gene patent
An unparalleled legal challenge has been underway in the EU regarding the number of human gene patents held by US-based corporation Myriad Genetics.
Intergroup Exemestane Study (IES) results
Currently, five years of treatment with tamoxifen is considered the 'gold-standard' treatment for postmenopausal women with breast cancer. This drug blocks oestrogen, which can help fuel the growth of tumours in some cases.
New concepts for breast care
The new Emscher-Lippe Breast Care Centre, based in the Marienhospital in Gelsenkirchen, but serving six hospitals* and four private practices, was established following a directive issued by Germany's North Rhine-Westphalia regional government.
Small wireless device to improve cancer treatment
USA - Engineers are developing a tiny wireless device - the size of a rice grain - to be implanted in tumours to indicate the precise radiation dose received and to locate the exact position of tumours during treatment.
Worldwide about 600,000 new cases of breast cancer are diagnosed annually
Mammography plays a critical part in diagnosing breast cancer. Although this does not prevent the disease, diagnosing breast cancer as early as possible can save lives.
World's lowest radiation doses
The Swedish firm Sectra reports that its digital MicroDose Mammography system reduces radiation by 80%, compared with traditional film-based systems, and that its completely new detection technology allows this without compromising image quality.
No reimbursement for digital screening
Interviewed by Daniela Zimmermann, Executive Director of EH, Jean Hooks, General Manager, Global Mammography at GE Healthcare, examined reasons behind the slow uptake of digital technology in some European countries, comparing this with its early adoption in the USA
All-in-one digital mammography
Siemens Medical Solutions reports that the first installations have been completed in France, Germany, Italy and Sweden of its new all-in-one system for digital full-field mammography, named Mammomat Novation.
Automated screening & reduced biopsies
Although X-ray mammography can detect small cancers before they have spread. However, because abnormalities can only be identified non-specifically, percutaneous or surgical breast biopsy must follow - but less than 20% of women recalled for biopsies have cancer.
BREAST THERAPIES
Ballon Brachytherapy and effective drug combination.
Mobile mammography goes digital
Financed by the Ministry of Health, nine regional screening organisations arrange and implement the Dutch national breast cancer screening programme, in which, every two years, all women from 50-75 years of age are invited for a free mammogram at one of the 62 screening points, of which 56 are mobile vans.
Ploughing vigorously forward
The UK - In the 1990s, the nationally co-ordinated NHS Breast Screening Programme was already saving lives - a 21% fall in breast cancer mortality over the last decade and, with the cervical screening programme, this was viewed as among the best cancer screening programmes in the world. However, in that period, the country's cancer services, as a whole did not match up to those of other European…
Quality assurance first
Germany's Federal Committee of Physicians and Statutory Health Insurance Funds set up three model projects, based in Bremen, Wiesbaden and Weser-Ems, to trial the third edition of the European guidelines on healthcare within the German system and to develop the necessary organisational structures to make these work.
Weighing up the way to go
Austria is the only 'old' EU Member State that has not implemented a national breast cancer screening programme.
Efficient screening programmes
Modern methods and technology make it possible to combine out- and inpatient treatment through comprehensive, overlapping systems and to standardise and optimise early diagnosis, therapy and aftercare for malignant diseases of the female breast regionally.
PET and recurrent cancer
More sensitive dissemination tests are needed for patients with locoregionally recurrent (LRR) breast cancer, according to a paper by Dutch researchers published online by the European Journal of Cancer (Volume 40, Issue 10 , 7/2004).
Ultrasound CT for early diagnosis
Karlsruhe, Germany - A new type of ultrasound computed tomography (CT) system promising to improve diagnosis significantly is currently being developed at the Research Centre Karlsruhe.
Why screen?
Mammography as a diagnostic procedure to evaluate detected tumours is not an issue. But because the technique is performed, in screening programmes, on apparently healthy people, for ethical reasons it becomes an issue.
Alcohol ups colon cancer risk
Denmark - Regular drinkers significantly increase their risk of rectal cancer, but that risk is reduced if wine makes up a third or more of weekly consumption, according to research carried out by Professor Morten Grønbaek, at the Centre for Alcohol Research, National Institute of Public Health, Copenhagen, published in the journal GUT.
Titanised ilicone breast implants
Implants presently in use consist of a smooth or textured silicone shell filled with a silicone gel or saline solution. The latter has one decisive drawback - the breast may cool considerably in winter. Smooth silicone implants may also shift or turn.
Article • Research, diagnostics, treatments
Focus on breast cancer
Breast cancer (breast carcinoma; often abbreviated as BRCA) is the most common cancer in women in many countries and the cancer with the highest mortality rate. The diagnostic and therapeutic options for breast cancer are correspondingly diverse. Keep reading for latest developments in early detection, staging, treatment and research.